Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Triple Negative Breast Neoplasms × Cromolyn Sodium × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Carboplatin 10 Paclitaxel 8 pembrolizumab 7 Cyclophosphamide 7 toripalimab 5 Drug Therapy 4 Doxorubicin 4 130-nm albumin-bound paclitaxel 4 sacituzumab govitecan 3 olaparib 3 eribulin 3 Specimen Handling 3 Epirubicin 3 Capecitabine 3 Biopsy 3 trastuzumab deruxtecan 2 Radiotherapy 2 Immune Checkpoint Inhibitors 2 Everolimus 2 tislelizumab 1 poly ICLC 1 pirfenidone 1 palbociclib 1 ivarmacitinib 1 inavolisib 1 fludarabine 1 daratumumab 1 camrelizumab 1 anlotinib 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07419880 2026-02-19

RECLAIM

Fudan University

Phase 2 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡